| P50 | author | Willem de Vos | Q8003634 |
| | Patrice D. Cani | Q30505257 |
| P2860 | cites work | The gut microbiota and host health: a new clinical frontier | Q26785649 |
| | Expert consensus document. The International Scientific Association for Probiotics and Prebiotics consensus statement on the scope and appropriate use of the term probiotic | Q28241661 |
| | Dietary modulation of the human colonic microbiota: introducing the concept of prebiotics | Q28303404 |
| | Inulin-type fructans modulate gastrointestinal peptides involved in appetite regulation (glucagon-like peptide-1 and ghrelin) in rats | Q60843307 |
| | Mucolytic Bacteria With Increased Prevalence in IBD Mucosa Augment In Vitro Utilization of Mucin by Other Bacteria | Q61782517 |
| | Diet rapidly and reproducibly alters the human gut microbiome | Q29547454 |
| | Metabolic endotoxemia initiates obesity and insulin resistance | Q29547720 |
| | Cross-talk between Akkermansia muciniphila and intestinal epithelium controls diet-induced obesity | Q29615051 |
| | Changes in gut microbiota control inflammation in obese mice through a mechanism involving GLP-2-driven improvement of gut permeability | Q29617378 |
| | Gut microbiota — at the intersection of everything? | Q30224289 |
| | Health Effects of Overweight and Obesity in 195 Countries over 25 Years | Q30402965 |
| | Akkermansia muciniphila gen. nov., sp. nov., a human intestinal mucin-degrading bacterium. | Q30962119 |
| | Personalized Nutrition by Prediction of Glycemic Responses. | Q33445995 |
| | Morbidity and mortality associated with obesity | Q33592804 |
| | Gut microbiota is a key modulator of insulin resistance in TLR 2 knockout mice | Q34097751 |
| | Functional genomics of lactic acid bacteria: from food to health | Q34139851 |
| | Prebiotic effects: metabolic and health benefits | Q34141652 |
| | Microbiome of prebiotic-treated mice reveals novel targets involved in host response during obesity | Q34175068 |
| | Microbes inside--from diversity to function: the case of Akkermansia | Q34205377 |
| | Consumption of diets high in prebiotic fiber or protein during growth influences the response to a high fat and sucrose diet in adulthood in rats | Q34217134 |
| | High-level colonisation of the human gut by Verrucomicrobia following broad-spectrum antibiotic treatment | Q34321185 |
| | Akkermansia muciniphila and improved metabolic health during a dietary intervention in obesity: relationship with gut microbiome richness and ecology | Q34481919 |
| | Human milk: a source of more life than we imagine | Q34524241 |
| | An increase in the Akkermansia spp. population induced by metformin treatment improves glucose homeostasis in diet-induced obese mice | Q34785134 |
| | Diet dominates host genotype in shaping the murine gut microbiota | Q34978394 |
| | Human gut microbiota changes reveal the progression of glucose intolerance | Q34980773 |
| | Gut microbiota signatures predict host and microbiota responses to dietary interventions in obese individuals | Q35113086 |
| | Impact of diet and individual variation on intestinal microbiota composition and fermentation products in obese men | Q35157012 |
| | Modulation of Mucosal Immune Response, Tolerance, and Proliferation in Mice Colonized by the Mucin-Degrader Akkermansia muciniphila. | Q35157719 |
| | Responses of gut microbiota and glucose and lipid metabolism to prebiotics in genetic obese and diet-induced leptin-resistant mice | Q35405358 |
| | Insights into the role of the microbiome in obesity and type 2 diabetes | Q35533602 |
| | Talking microbes: When gut bacteria interact with diet and host organs | Q35692988 |
| | Intestinal mucosal adherence and translocation of commensal bacteria at the early onset of type 2 diabetes: molecular mechanisms and probiotic treatment. | Q35693573 |
| | Postnatal prebiotic fibre intake mitigates some detrimental metabolic outcomes of early overnutrition in rats | Q35788930 |
| | Akkermansia muciniphila inversely correlates with the onset of inflammation, altered adipose tissue metabolism and metabolic disorders during obesity in mice | Q35840309 |
| | Disentangling type 2 diabetes and metformin treatment signatures in the human gut microbiota | Q35860108 |
| | Endocannabinoids--at the crossroads between the gut microbiota and host metabolism. | Q35871872 |
| | Red pitaya betacyanins protects from diet-induced obesity, liver steatosis and insulin resistance in association with modulation of gut microbiota in mice | Q35877220 |
| | Sub-clinical detection of gut microbial biomarkers of obesity and type 2 diabetes | Q35925547 |
| | Nondigestible Fructans Alter Gastrointestinal Barrier Function, Gene Expression, Histomorphology, and the Microbiota Profiles of Diet-Induced Obese C57BL/6J Mice | Q35981706 |
| | Low-Density Lipoprotein Receptor Signaling Mediates the Triglyceride-Lowering Action of Akkermansia muciniphila in Genetic-Induced Hyperlipidemia. | Q36031475 |
| | Akkermansia muciniphila: a novel functional microbe with probiotic properties | Q36049652 |
| | Mango Supplementation Modulates Gut Microbial Dysbiosis and Short-Chain Fatty Acid Production Independent of Body Weight Reduction in C57BL/6 Mice Fed a High-Fat Diet | Q36064485 |
| | Prebiotics and other microbial substrates for gut functionality | Q36098527 |
| | Microbiota Diurnal Rhythmicity Programs Host Transcriptome Oscillations | Q36212153 |
| | Pili-like proteins of Akkermansia muciniphila modulate host immune responses and gut barrier function | Q36294173 |
| | The Mucin degrader Akkermansia muciniphila is an abundant resident of the human intestinal tract | Q36483117 |
| | Human milk metagenome: a functional capacity analysis | Q36922107 |
| | Akkermansia muciniphila mediates negative effects of IFNγ on glucose metabolism | Q37421598 |
| | Gut microbiota dysbiosis contributes to the development of hypertension. | Q37618646 |
| | Characterization of Outer Membrane Proteome of Akkermansia muciniphila Reveals Sets of Novel Proteins Exposed to the Human Intestine | Q37835876 |
| | Prebiotic approach alleviates hepatic steatosis: implication of fatty acid oxidative and cholesterol synthesis pathways | Q38319585 |
| | Isomalto-oligosaccharides, a prebiotic, functionally augment green tea effects against high fat diet-induced metabolic alterations via preventing gut dysbacteriosis in mice | Q38698364 |
| | Recovery of ethanol-induced Akkermansia muciniphila depletion ameliorates alcoholic liver disease. | Q38760769 |
| | Childhood predictors of cardiovascular disease in adulthood. A systematic review and meta-analysis | Q38763426 |
| | Metformin Is Associated With Higher Relative Abundance of Mucin-Degrading Akkermansia muciniphila and Several Short-Chain Fatty Acid-Producing Microbiota in the Gut. | Q38780040 |
| | Targeting the gut microbiota with inulin-type fructans: preclinical demonstration of a novel approach in the management of endothelial dysfunction. | Q38854649 |
| | Intestinal microbiome landscaping: insight in community assemblage and implications for microbial modulation strategies | Q38863317 |
| | Toll-like receptor 2 regulates intestinal inflammation by controlling integrity of the enteric nervous system | Q39102142 |
| | Adaptation of Akkermansia muciniphila to the oxic-anoxic interface of the mucus layer | Q39356981 |
| | Expert consensus document: The International Scientific Association for Probiotics and Prebiotics (ISAPP) consensus statement on the definition and scope of prebiotics. | Q39370710 |
| | Factors Influencing the Gut Microbiota, Inflammation, and Type 2 Diabetes. | Q39374045 |
| | Akkermansia Muciniphila Protects Against Atherosclerosis by Preventing Metabolic Endotoxemia-Induced Inflammation in Apoe-/- Mice | Q40688485 |
| | NLRP6 Protects Il10-/- Mice from Colitis by Limiting Colonization of Akkermansia muciniphila | Q41130908 |
| | Aguamiel concentrate from Agave salmiana and its extracted saponins attenuated obesity and hepatic steatosis and increased Akkermansia muciniphila in C57BL6 mice | Q41203375 |
| | Intestinal integrity and Akkermansia muciniphila, a mucin-degrading member of the intestinal microbiota present in infants, adults, and the elderly. | Q42909140 |
| | Inulin with different degrees of polymerization modulates composition of intestinal microbiota in mice | Q46383946 |
| | Maternal weight and excessive weight gain during pregnancy modify the immunomodulatory potential of breast milk | Q46702666 |
| | A polyphenol-rich cranberry extract protects from diet-induced obesity, insulin resistance and intestinal inflammation in association with increased Akkermansia spp. population in the gut microbiota of mice. | Q46858371 |
| | A purified membrane protein from Akkermansia muciniphila or the pasteurized bacterium improves metabolism in obese and diabetic mice | Q48052752 |
| | Improvement of glucose tolerance and hepatic insulin sensitivity by oligofructose requires a functional glucagon-like peptide 1 receptor. | Q51498948 |
| | Inulin-type fructans with prebiotic properties counteract GPR43 overexpression and PPARγ-related adipogenesis in the white adipose tissue of high-fat diet-fed mice | Q60843055 |
| P921 | main subject | Akkermansia muciniphila | Q15020908 |
| P304 | page(s) | 1765 | |
| P577 | publication date | 2017-09-22 | |
| P1433 | published in | Frontiers in Microbiology | Q27723481 |
| P1476 | title | Next-Generation Beneficial Microbes: The Case of Akkermansia muciniphila | |
| P478 | volume | 8 | |